Tin tức & Cập nhật
Lọc theo Chuyên ngành:
Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection
Ten-day treatment with vonoprazan 20 mg twice/day plus amoxicillin 750 mg four times/day (VHA-dual) as a first-line therapy for Helicobacter pylori infection results in satisfactory eradication rate of >90 percent, fewer adverse events (AEs), and similar adherence when compared with bismuth quadruple therapy (B-quadruple), results of a study have shown.
Vonoprazan-amoxicillin combo on par with B-quadruple therapy for H. pylori infection
23 Apr 2023
Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae
Sleep disruption following hospital admission for COVID-19 is associated with dyspnoea, anxiety, and muscle weakness in the CircCOVID cohort sub-study presented at ECCMID 2023.
Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae
22 Apr 2023
Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients
In vaccinated adults with COVID-19 who are at higher risk of adverse outcomes, treatment with molnupiravir in addition to usual care falls short of reducing the rates of hospitalizations and deaths, as shown by the results of the PANORAMIC study.
